Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes
- 26 May 2012
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 55 (9) , 2348-2355
Abstract
The optimal HbA1c concentration for prevention of macrovascular complications and deaths in obese cardiovascular high-risk patients with type 2 diabetes remains to be established and was therefore studied in this post hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial, which enrolled overweight and obese patients with type 2 diabetes and/or cardiovascular disease.Keywords
This publication has 34 references indexed in Scilit:
- Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trialDiabetes, Obesity and Metabolism, 2011
- Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsBMJ, 2011
- Glycemic Control, Complications, and Death in Older Diabetic PatientsDiabetes Care, 2011
- A1C and Cardiovascular Outcomes in Type 2 DiabetesDiabetes Care, 2010
- Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD TrialDiabetes Care, 2010
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older womenDiabetologia, 2007
- Relation of Loop Diuretic Dose to Mortality in Advanced Heart FailureThe American Journal of Cardiology, 2006
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationAmerican Heart Journal, 1986